<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>bcl-2 is a proto-oncogene discovered through the t(14;18) translocation occurring in most human follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The function so far attributed to bcl-2 is to counteract the occurrence of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and to prolong cell survival without affecting the cycling cells </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> has been described in <z:mpath ids='MPATH_458'>normal</z:mpath> breast tissue epithelial cells, and it peaks at the end of the luteal phase </plain></SENT>
<SENT sid="3" pm="."><plain>We have studied bcl-2 expression by an immunohistochemical method in 50 samples of <z:mpath ids='MPATH_458'>normal</z:mpath> breast tissue distributed throughout the menstrual cycle </plain></SENT>
<SENT sid="4" pm="."><plain>bcl-2 staining predominated in the lobular epithelial cells </plain></SENT>
<SENT sid="5" pm="."><plain>It displayed a striking cyclic variation, with maximal expression at the mid-cycle period and a sharp decrease at the end of the cycle </plain></SENT>
<SENT sid="6" pm="."><plain>These results strongly suggest that the regulation of bcl-2 expression in breast tissue is hormone-dependent </plain></SENT>
<SENT sid="7" pm="."><plain>This could be of significance in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>